Disposable vapes to be banned over fears for children's health
Rishi Sunak announces the plan saying “we must act” to tackle a rise in vaping among children.
Similar Posts
WHO warns pandemic treaty deadline may be missed
Join Fox News for access to this content Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the…
Johnson & Johnson (JNJ) earnings Q4 2023
The stock trading graph of Johnson & Johnson is seen on a smartphone screen. Rafael Henrique | SOPA Images | LightRocket | Getty Images Johnson & Johnson on Tuesday reported fourth-quarter earnings and revenue that narrowly edged out Wall Street’s expectations as sales in the company’s pharmaceutical and medical devices businesses surged. J&J also provided full-year…
Covid Inquiry: What have we learnt so far?
The first phase of the Covid Inquiry has come to an end. What have we learnt over the past six weeks?
Covid inquiry: Bereaved daughters want lessons learned
Campaigners said they were not satisfied with Boris Johnson’s answers at the Covid inquiry.
Business | Fitness - Gym | Health | Nutrition Life | Sports | Technology | Uncategorized
The Rise of Wearable Fitness Tech: Are You Keeping Up?
Fitness has come a long way from notepads and stopwatch timers. In todayâs world, wearable fitness technology is redefining how we approach health, exercise, and everyday habits. Whether you’re a serious athlete or someone simply trying to walk more, wearables are changing the gameâand if you haven’t jumped on the bandwagon yet, it’s worth asking:…
These 4 anti-obesity drug stocks could soar, Berenberg says
The anti-obesity drug market is expected to remain in focus this year after a bumper 2023 for weight loss drugmakers Novo Nordisk and Eli Lilly , according to Berenberg. The Germany-headquartered investment bank expects a combination of new clinical data, and the expiry of Novo ‘s patent for the active ingredient in first-generation GLP-1 drugs,…